Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Maternal Peripheral Blood
- Study HIC#:2000030949
- Last Updated:04/21/2023
The purpose of this study is to develop a risk-free noninvasive prenatal diagnosis procedure for genetic conditions in the developing fetus by studying fetal cells in maternal blood.
- Age18 years and older
- GenderFemale only
Contact Us
For more information about this study, including how to volunteer, contact:
Audrey Merriam
- Phone Number: 1-203-785-5855
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
Trial Purpose and Description
The purpose of this study is to develop a risk-free noninvasive prenatal diagnosis procedure for genetic conditions in the developing fetus by studying fetal cells in maternal blood.
Eligibility Criteria
Eligibility Criteria:
- >/= 18yo, singleton or twin gestation
- planning to undergo CVS or amniocentesis
